DSIP mastery course
Unit 8 of 11

DSIP in context & regulatory status

To judge DSIP fairly, set it beside the sleep drugs that did make it: melatonin agonists, the orexin antagonists (DORAs…

How DSIP compares to real sleep medicines, and why it never became one

To judge DSIP fairly, set it beside the sleep drugs that did make it: melatonin agonists, the orexin antagonists (DORAs), and the GABAergic hypnotics. The contrast is stark, not in mechanism, but in the depth of evidence and the existence of regulatory approval.

This unit places DSIP in that landscape, lays out its actual regulatory status, and explains the specific reasons its development stalled while modern insomnia drugs advanced.

Key terms

The modern sleep-drug landscape


DSIP versus melatonin


Scoring the classes side by side


The regulatory reality


Why development stalled